Galletta Christopher (CIK 1486099) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-03). Recent activity: Buy TRVI (4,225 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-03 | Trevi Therapeutics, Inc. (TRVI) | See Remarks | Buy | 4,225 | $2,155 |
Source: SEC Form 4 filings · as of 2025-12-03